ATAI BECKLEY NV (ATAI) Stock News

USA - Nasdaq - NASDAQ:ATAI - NL0015000DX5 - Common Stock

4.06 USD

+0.19 (+4.91%)

Last: 12/3/2025, 1:17:03 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

ATAI Latest News, Press Relases and Analysis

All

Press Releases

14 days ago - By: Enhanced

News Image

Enhanced Fortifies Executive Leadership Team & Board of Directors

20 days ago - By: AtaiBeckley N.V.

AtaiBeckley to Participate in the Jefferies Global Healthcare Conference in London

20 days ago - By: AtaiBeckley N.V.

AtaiBeckley to Participate in the Jefferies Global Healthcare Conference in London

21 days ago - By: AtaiBeckley N.V.

AtaiBeckley Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

21 days ago - By: AtaiBeckley N.V.

AtaiBeckley Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

a month ago - By: Benzinga

Analyst Expectations For ATAI Life Sciences's Future

23 days ago - By: AtaiBeckley N.V.

AtaiBeckley Announces Positive Topline Data from the Phase 2b Open-Label Extension Study of BPL-003, Supporting Safety and Efficacy of a Second Dose in Patients with Treatment-Resistant Depression

a month ago - By: AtaiBeckley N.V.

atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies

a month ago - By: AtaiBeckley N.V.

atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies

2 months ago - By: Benzinga

Demystifying ATAI Life Sciences: Insights From 5 Analyst Reviews

a month ago - By: atai Life Sciences

atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares

a month ago - By: atai Life Sciences

atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares

a month ago - By: Zacks Investment Research

atai Life Sciences (ATAI) Upgraded to Buy: Here's Why

2 months ago - By: The Motley Fool

Why Atai Life Sciences Stock Was So Lively This Week

2 months ago - By: atai Life Sciences

atai Life Sciences Announces Pricing of Public Offering of Common Shares

2 months ago - By: atai Life Sciences

atai Life Sciences Announces Pricing of Public Offering of Common Shares

2 months ago - By: atai Life Sciences

atai Life Sciences Announces Proposed Public Offering of Common Shares

2 months ago - By: atai Life Sciences

atai Life Sciences Announces Proposed Public Offering of Common Shares

2 months ago - By: atai Life Sciences

atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression

2 months ago - By: atai Life Sciences

atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression

2 months ago - By: The Motley Fool

Why Atai Life Sciences Stock Crushed It on Tuesday

2 months ago - By: atai Life Sciences

atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression

2 months ago - By: atai Life Sciences

atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression

3 months ago - By: atai Life Sciences

atai Life Sciences Awarded Grant from the National Institutes of Health

3 months ago - By: atai Life Sciences

atai Life Sciences Awarded Grant from the National Institutes of Health

3 months ago - By: Zacks Investment Research - Mentions: HALO

Are Medical Stocks Lagging Halozyme Therapeutics (HALO) This Year?

3 months ago - By: atai Life Sciences

atai Life Sciences to Participate in September Investor Conferences

3 months ago - By: atai Life Sciences

atai Life Sciences to Participate in September Investor Conferences

4 months ago - By: Zacks Investment Research

Here's Why atai Life Sciences (ATAI) Is a Great 'Buy the Bottom' Stock Now

4 months ago - By: atai Life Sciences

atai Life Sciences Reports Second Quarter 2025 Financial Results and Recent Corporate Updates

4 months ago - By: atai Life Sciences

atai Life Sciences Reports Second Quarter 2025 Financial Results and Recent Corporate Updates

4 months ago - By: Yahoo Finance

H.C. Wainwright Lifts PT on Atai Life Sciences (ATAI) to $15 From $10